home / stock / mthry / mthry quote
Last: | $4.92 |
---|---|
Change Percent: | 0.76% |
Open: | $4.972 |
Close: | $4.92 |
High: | $4.98 |
Low: | $4.92 |
Volume: | 267,155 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.92 | $4.972 | $4.92 | $4.98 | $4.92 | 267,155 | 07-19-2024 |
$5.01 | $5.055 | $5.01 | $5.09 | $4.97 | 82,029 | 07-18-2024 |
$4.98 | $4.955 | $4.98 | $5.02 | $4.942 | 47,119 | 07-17-2024 |
$4.94 | $4.82 | $4.94 | $4.94 | $4.7501 | 49,539 | 07-16-2024 |
$5.03 | $5.035 | $5.03 | $5.08 | $5.01 | 87,849 | 07-15-2024 |
$5.06 | $4.85 | $5.06 | $5.07 | $4.85 | 24,394 | 07-12-2024 |
$4.79 | $4.735 | $4.79 | $4.865 | $4.735 | 135,831 | 07-11-2024 |
$4.74 | $4.585 | $4.74 | $4.74 | $4.585 | 232,059 | 07-10-2024 |
$4.72 | $4.715 | $4.72 | $4.753 | $4.66 | 189,910 | 07-09-2024 |
$4.65 | $4.5875 | $4.65 | $4.78 | $4.52 | 107,809 | 07-08-2024 |
$4.65 | $4.54 | $4.65 | $4.66 | $4.54 | 113,490 | 07-05-2024 |
$4.63 | $4.65 | $4.63 | $4.6725 | $4.62 | 35,048 | 07-04-2024 |
$4.63 | $4.65 | $4.63 | $4.6725 | $4.62 | 35,048 | 07-03-2024 |
$4.6365 | $4.6 | $4.6365 | $4.65 | $4.59 | 283,819 | 07-02-2024 |
$4.6 | $4.695 | $4.6 | $4.73 | $4.55 | 181,420 | 07-01-2024 |
$4.77 | $4.76 | $4.77 | $4.8 | $4.735 | 196,666 | 06-28-2024 |
$4.83 | $4.785 | $4.83 | $4.88 | $4.785 | 152,333 | 06-27-2024 |
$4.76 | $4.75 | $4.76 | $4.79 | $4.66 | 143,446 | 06-26-2024 |
$4.74 | $4.75 | $4.74 | $4.77 | $4.7201 | 245,012 | 06-25-2024 |
$4.67 | $4.655 | $4.67 | $4.7 | $4.5771 | 266,658 | 06-24-2024 |
News, Short Squeeze, Breakout and More Instantly...
M3 Company Name:
MTHRY Stock Symbol:
OTCMKTS Market:
M3 WAKE RESEARCH EXPANDS INTO CHARLESTON, SC PR Newswire New Partnership Adds Award-winning Clinical Research Leader, Dr. Donald Hurley , to Wake Research's National Network CHARLESTON, S.C. , July 7, 2023 /PRNewswire/ -- M3 Wake Research, a leadi...
M3 WAKE RESEARCH POISED TO EXPAND PHASE I TRIAL SERVICES PR Newswire New Executive Role Will Lead Growth of Phase I Trial Operations Beyond RTP RALEIGH, N.C. , March 7, 2023 /PRNewswire/ -- M3 Wake Research, a leading fully integrated network of clinical ...
M3-WAKE RESEARCH ACQUIRES MULTI-SPECIALTY RESEARCH ASSOCIATES OF LAKE CITY, FLORIDA PR Newswire Addition of Well-Established Clinical Research Site Expands Operations into Florida , Offers Multi-specialty Expertise including Vaccines, Primary Care, and Women's Heal...